Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 3 (1)

Trial Status

Unknown4
Enrolling By Invitation1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07363980Enrolling By Invitation

Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study

NCT06738381Not ApplicableRecruiting

Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease

NCT05004675Phase 3Completed

Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients

NCT03683628Not ApplicableUnknown

Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC

NCT03686228Not ApplicableUnknown

Treatment of No-option CLI by G-CSF-mobilized PB-MNC

NCT04583436Not ApplicableUnknownPrimary

Efficacy and Safety Comparison of the Open and Endovascular Surgical Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Below the Knee, TASC D in Patients With Critical Limb Ischemia

NCT03098771Not ApplicableUnknownPrimary

Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly

Showing all 7 trials

Research Network

Activity Timeline